株探米国株
エドガーで原本を確認する
false000070754900007075492026-07-292026-07-29
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
 Current Report
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): July 29, 2026
  LAM RESEARCH CORPORATION
(Exact name of registrant as specified in its charter)
 
Delaware   0-12933   94-2634797
(State or Other Jurisdiction
of Incorporation)		   (Commission
File Number)		   (IRS Employer
Identification Number)
4650 Cushing Parkway
Fremont, California 94538
(Address of principal executive offices including zip code)
(510) 572-0200
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol Name of each exchange on which registered
Common Stock, Par Value $0.001 Per Share LRCX The Nasdaq Stock Market
(Nasdaq Global Select Market)
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company      ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.                      ☐

Table of Contents
Table of Contents
 
Item 2.02.    Results of Operations and Financial Condition
Item 9.01.    Financial Statements and Exhibits
SIGNATURES
EX-99.1


Table of Contents
 Item 2.02. Results of Operations and Financial Condition
On July 29, 2026, Lam Research Corporation (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended June 28, 2026, the text of which is attached hereto as Exhibit 99.1.
The information in this item of this Current Report on Form 8-K, including Exhibit 99.1, is furnished pursuant to Item 2.02 and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section. Furthermore, the information in this item of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Exchange Act.
 Item 9.01. Financial Statements and Exhibits
(d) Exhibits
99.1
104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document


Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: July 29, 2026
LAM RESEARCH CORPORATION
(Registrant)
  /s/ Douglas R. Bettinger
  Douglas R. Bettinger
  Executive Vice President and Chief Financial Officer
  (Principal Financial Officer)
 


EX-99.1 2 lrcx_exhibitx991xq4x2026.htm EX-99.1 Document

Exhibit 99.1
FOR IMMEDIATE RELEASE        
Lam Research Corporation Reports Financial Results for the Quarter Ended June 28, 2026
FREMONT, Calif., July 29, 2026 - Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended June 28, 2026 (the “June 2026 quarter”).
Highlights for the June 2026 quarter were as follows:
•Revenue of $6.72 billion.
•U.S. GAAP gross margin as a percent of revenue of 51.7%, U.S. GAAP operating margin as a percent of revenue of 37.4%, and U.S. GAAP diluted EPS of $1.81.
•Non-GAAP gross margin as a percent of revenue of 52.0%, non-GAAP operating margin as a percent of revenue of 38.4%, and non-GAAP diluted EPS of $1.82.
Key Financial Data for the Quarters Ended
June 28, 2026 and March 29, 2026
(in thousands, except per-share data, percentages, and basis points) 
U.S. GAAP
  June 2026 March 2026 Change Q/Q
Revenue $ 6,722,238  $ 5,841,488  +15.1%
Gross margin 51.7  % 49.8  % + 190 bps
Operating margin 37.4  % 35.0  % + 240 bps
Diluted EPS $ 1.81  $ 1.45  +24.8%
Non-GAAP
  June 2026 March 2026 Change Q/Q
Revenue $ 6,722,238  $ 5,841,488  +15.1%
Gross margin 52.0  %   49.9  % + 210 bps
Operating margin 38.4  %   35.0  % + 340 bps
Diluted EPS $ 1.82    $ 1.47  +23.8%
U.S. GAAP Financial Results
For the June 2026 quarter, revenue was $6.72 billion, gross margin was $3.48 billion, or 51.7% of revenue, operating expenses were $965.3 million, operating margin was 37.4% of revenue, and net income was $2.28 billion, or $1.81 per diluted share on a U.S. GAAP basis. This compares to revenue of $5.84 billion, gross margin of $2.91 billion, or 49.8% of revenue, operating expenses of $863.5 million, operating margin of 35.0% of revenue, and net income of $1.83 billion, or $1.45 per diluted share, for the quarter ended March 29, 2026 (the “March 2026 quarter”).
Non-GAAP Financial Results
For the June 2026 quarter, non-GAAP gross margin was $3.50 billion, or 52.0% of revenue, non-GAAP operating expenses were $916.4 million, non-GAAP operating margin was 38.4% of revenue, and non-GAAP net income was $2.28 billion, or $1.82 per diluted share. This compares to non-GAAP gross margin of $2.91 billion, or 49.9% of revenue, non-GAAP operating expenses of $866.2 million, non-GAAP operating margin of 35.0% of revenue, and non-GAAP net income of $1.85 billion, or $1.47 per diluted share, for the March 2026 quarter.
“Lam delivered record revenue, operating margin and earnings per share in the June quarter as AI-driven demand continues to reshape the semiconductor industry,” said Tim Archer, Lam Research's President and Chief Executive Officer. “Our strategic investments and technology leadership are helping customers accelerate through rising manufacturing complexity, positioning Lam for a third consecutive year of outperformance in 2026.”







Balance Sheet and Cash Flow Results
Cash, cash equivalents, and restricted cash balances increased to $5.60 billion at the end of the June 2026 quarter compared to $4.77 billion at the end of the March 2026 quarter. The increase was primarily driven by cash generated from operating activities, partially offset by cash deployed for capital return activities during the quarter.
Deferred revenue at the end of the June 2026 quarter increased to $2.43 billion compared to $2.22 billion as of the end of the March 2026 quarter. Lam's deferred revenue balance does not include shipments to customers in Japan, to whom title does not transfer until customer acceptance. Shipments to customers in Japan are classified as inventory at cost until the time of acceptance. The estimated future revenue from shipments to customers in Japan was approximately $490.2 million as of June 28, 2026 and $434.3 million as of March 29, 2026.
Revenue
The geographic distribution of revenue during the June 2026 quarter is shown in the following table:
Region Revenue
Taiwan 27%
China 26%
Korea 20%
Japan 9%
United States 9%
Southeast Asia 5%
Europe 4%
The following table presents revenue disaggregated between systems and customer support-related revenue:
Three Months Ended
June 28,
2026		 March 29,
2026		 June 29,
2025
(In thousands)
Systems revenue $ 4,249,848  $ 3,730,582  $ 3,437,625 
Customer support-related revenue and other 2,472,390  2,110,906  1,733,768 
$ 6,722,238  $ 5,841,488  $ 5,171,393 
Systems revenue includes sales of new leading-edge equipment in deposition, etch and other wafer fabrication markets.
Customer support-related revenue includes sales of customer service, spares, upgrades, and non-leading-edge equipment from our Reliant® product line.
Outlook
For the quarter ended September 27, 2026, Lam is providing the following guidance:
U.S. GAAP Reconciling Items Non-GAAP
Revenue $8.10 Billion +/- $400 Million — $8.10 Billion +/- $400 Million
Gross margin 52.0% +/- 1% $ 2.7  Million 52.0% +/- 1%
Operating margin 39.5% +/- 1% $ 3.0  Million 39.5% +/- 1%
Net income per diluted share $2.15 +/- $0.15 $ 3.3  Million $2.15 +/- $0.15
Diluted share count 1.255 Billion — 1.255 Billion
The information provided above is only an estimate of what the Company believes is realizable as of the date of this release and does not incorporate the potential impact of any business combinations, asset acquisitions, divestitures, restructuring, balance sheet valuation adjustments, financing arrangements, other investments, or other items that may be completed or realized after the date of this release, except as described below. U.S. GAAP to non-GAAP reconciling items provided include only those items that are known and can be estimated as of the date of this release. Actual results will vary from this model and the variations may be material. Reconciling items included above are as follows:


•Gross margin - amortization related to intangible assets acquired through business combinations, $2.7 million.
•Operating margin - amortization related to intangible assets acquired through business combinations, $3.0 million.
•Net income per diluted share - amortization related to intangible assets acquired though business combinations, $3.0 million; amortization of debt discounts, $0.5 million; and associated tax benefit for non-GAAP items ($0.2 million); totaling $3.3 million.
Use of Non-GAAP Financial Results
In addition to U.S. GAAP results, this press release also contains non-GAAP financial results. The Company’s non-GAAP results for both the June 2026 and March 2026 quarters exclude amortization related to intangible assets acquired through business combinations, the effects of elective deferred compensation-related assets and liabilities, amortization of note discounts, workforce optimization charges, and the net income tax effect of non-GAAP items.
Management uses non-GAAP gross margin, operating expense, operating income, operating margin, net income, and net income per diluted share to evaluate the Company’s operating and financial results. The Company believes the presentation of non-GAAP results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing investors’ ability to view the Company’s results from management’s perspective. Tables presenting reconciliations of non-GAAP results to U.S. GAAP results are included at the end of this press release and on the Company’s website at https://investor.lamresearch.com.
Caution Regarding Forward-Looking Statements
Statements made in this press release that are not of historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to, but are not limited to: our outlook and guidance for future financial results, including revenue, gross margin, operating margin, net income per diluted share, and diluted share count; the effect of AI-driven demand on the semiconductor industry; the rising complexity of semiconductor manufacturing and the extent to which our investments and technology leadership help customers; and our positioning for outperformance. Some factors that may affect these forward-looking statements include: business, economic, political and/or regulatory conditions in the consumer electronics industry, the semiconductor industry and the overall economy may deteriorate or change; the actions of our customers and competitors may be inconsistent with our expectations; trade regulations, export controls, tariffs, trade disputes, and other geopolitical tensions may inhibit our ability to sell our products; supply chain cost increases, tariffs, export controls and other inflationary pressures have impacted and may continue to impact our profitability; supply chain disruptions, export controls or manufacturing capacity constraints may limit our ability to manufacture and sell our products; and natural and human-caused disasters, disease outbreaks, war, terrorism, political or governmental unrest or instability, or other events beyond our control may impact our operations and revenue in affected areas; as well as the other risks and uncertainties that are described in the documents filed or furnished by us with the Securities and Exchange Commission, including specifically the Risk Factors described in our most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. These uncertainties and changes could materially affect the forward-looking statements and cause actual results to vary from expectations in a material way. The Company undertakes no obligation to update the information or statements made in this release.

Lam Research Corporation is a global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. Lam's equipment and services allow customers to build smaller and better performing devices. In fact, today, nearly every advanced chip is built with Lam technology. We combine superior systems engineering, technology leadership, and a strong values-based culture, with an unwavering commitment to our customers. Lam Research (Nasdaq: LRCX) is a FORTUNE 500® company headquartered in Fremont, Calif., with operations around the globe. Learn more at www.lamresearch.com. (LRCX)
Consolidated Financial Tables Follow.
 ###




 
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data and percentages)
  Three Months Ended Twelve Months Ended
  June 28,
2026		 March 29,
2026		 June 29,
2025		 June 28,
2026		 June 29,
2025
(unaudited) (unaudited) (unaudited) (unaudited) (1)
Revenue $ 6,722,238  $ 5,841,488  $ 5,171,393  $ 23,232,690  $ 18,435,591 
Cost of goods sold 3,243,498  2,930,961  2,581,684  11,507,382  9,456,532 
Gross margin 3,478,740  2,910,527  2,589,709  11,725,308  8,979,059 
Gross margin as a percent of revenue 51.7  % 49.8  % 50.1  % 50.5  % 48.7  %
Research and development 642,922  583,200  580,178  2,375,873  2,096,387 
Selling, general and administrative 322,330  280,311  268,403  1,149,640  981,704 
Total operating expenses 965,252  863,511  848,581  3,525,513  3,078,091 
Operating income 2,513,488  2,047,016  1,741,128  8,199,795  5,900,968 
Operating margin 37.4  % 35.0  % 33.7  % 35.3  % 32.0  %
Other income (expense), net 41,654  (35,460) 37,853  62,678  57,161 
Income before income taxes 2,555,142  2,011,556  1,778,981  8,262,473  5,958,129 
Income tax expense (277,860) (186,096) (58,893) (997,077) (599,912)
Net income $ 2,277,282  $ 1,825,460  $ 1,720,088  $ 7,265,396  $ 5,358,217 
Net income per share:
Basic $ 1.82  $ 1.46  $ 1.35  $ 5.79  $ 4.17 
Diluted $ 1.81  $ 1.45  $ 1.35  $ 5.76  $ 4.15 
Number of shares used in per share calculations:
Basic 1,251,286  1,249,728  1,274,279  1,255,079  1,286,101 
Diluted 1,256,032  1,257,325  1,276,933  1,261,102  1,290,142 
Cash dividend declared per common share $ 0.26  $ 0.26  $ 0.23  $ 1.04  $ 0.92 
(1) Derived from audited financial statements













 LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
 
June 28,
2026		 March 29,
2026		 June 29,
2025
(unaudited) (unaudited) (1)
ASSETS
Cash and cash equivalents $ 5,579,171  $ 4,750,936  $ 6,390,659 
Accounts receivable, net 5,339,682  4,132,890  3,378,071 
Inventories 4,276,111  3,999,992  4,307,991 
Prepaid expenses and other current assets 415,741  413,099  440,274 
Total current assets 15,610,705  13,296,917  14,516,995 
Property and equipment, net 2,956,472  2,853,614  2,428,744 
Goodwill and intangible assets 1,895,859  1,882,017  1,808,685 
Other assets 3,066,707  2,759,362  2,590,836 
Total assets $ 23,529,743  $ 20,791,910  $ 21,345,260 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current portion of long-term debt and finance lease obligations $ 4,073  $ 4,095  $ 754,311 
Other current liabilities 5,933,176  5,238,303  5,814,114 
Total current liabilities 5,937,249  5,242,398  6,568,425 
Long-term debt and finance lease obligations 3,730,490  3,730,384  3,730,194 
Income taxes payable 681,197  621,572  603,412 
Other long-term liabilities 709,886  612,777  581,610 
Total liabilities 11,058,822  10,207,131  11,483,641 
Stockholders’ equity (2) 12,470,921  10,584,779  9,861,619 
Total liabilities and stockholders’ equity $ 23,529,743  $ 20,791,910  $ 21,345,260 
 
(1) Derived from audited financial statements
(2)
Common shares issued and outstanding were 1,251,278 as of June 28, 2026, 1,250,539 as of March 29, 2026, and 1,268,740 as of June 29, 2025
 




 
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
  Three Months Ended Twelve Months Ended
  June 28,
2026		 March 29,
2026		 June 29,
2025		 June 28,
2026		 June 29,
2025
(unaudited) (unaudited) (unaudited) (unaudited) (1)
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income $ 2,277,282  $ 1,825,460  $ 1,720,088  $ 7,265,396  $ 5,358,217 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 119,642  116,322  98,439  441,533  386,277 
Deferred income taxes (175,752) (19,478) (151,679) (289,062) (363,247)
Equity-based compensation expense 103,985  96,616  94,286  386,381  343,371 
Other, net (8,006) (2,855) 14,240  (32,712) 6,845 
Changes in operating assets and liabilities (859,923) (874,645) 778,814  (1,913,879) 441,801 
Net cash provided by operating activities 1,457,228  1,141,420  2,554,188  5,857,657  6,173,264 
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures and intangible assets (188,801) (331,604) (172,191) (966,405) (759,186)
Other, net 45,060  (2,976) 42,940  44,253  51,094 
Net cash used for investing activities (143,741) (334,580) (129,251) (922,152) (708,092)
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on debt, including finance lease obligations and payments for debt issuance costs (1,355) (751,194) (1,485) (755,428) (507,488)
Treasury stock purchases, including excise tax payments (246,560) (1,162,837) (1,292,277) (3,851,343) (3,422,321)
Dividends paid (325,318) (325,829) (295,207) (1,270,635) (1,149,542)
Reissuance of treasury stock related to employee stock purchase plan 88,780  —  79,556  155,965  140,113 
Proceeds from issuance of common stock 4,426  9,167  696  17,447  2,452 
Other, net (282) 55  (820) (13,793) 143 
Net cash used for financing activities (480,309) (2,230,638) (1,509,537) (5,717,787) (4,936,643)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (2,056) (4,979) 29,284  (27,431) 28,324 
Net change in cash, cash equivalents, and restricted cash 831,122  (1,428,777) 944,684  (809,713) 556,853 
Cash, cash equivalents, and restricted cash at beginning of period (2) 4,766,821  6,195,598  5,462,972  6,407,656  5,850,803 
Cash, cash equivalents, and restricted cash at end of period (2) $ 5,597,943  $ 4,766,821  $ 6,407,656  $ 5,597,943  $ 6,407,656 
(1) Derived from audited financial statements
(2) Restricted cash is reported within Other assets in the Condensed Consolidated Balance Sheets



 
Non-GAAP Financial Summary
(in thousands, except percentages and per share data)
(unaudited)
Three Months Ended
June 28,
2026		 March 29,
2026
Revenue $ 6,722,238  $ 5,841,488 
Gross margin $ 3,497,336  $ 2,913,123 
Gross margin as percent of revenue 52.0  % 49.9  %
Operating expenses $ 916,420  $ 866,166 
Operating income $ 2,580,916  $ 2,046,957 
Operating margin 38.4  % 35.0  %
Net income $ 2,279,968  $ 1,851,442 
Net income per diluted share $ 1.82  $ 1.47 
Shares used in per share calculation - diluted 1,256,032  1,257,325 
Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income
(in thousands, except per share data)
(unaudited) 
Three Months Ended
June 28,
2026		 March 29,
2026
U.S. GAAP net income $ 2,277,282  $ 1,825,460 
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations - cost of goods sold 2,668  2,668 
Elective deferred compensation ("EDC") related liability valuation increase (decrease) - cost of goods sold 15,379  (6,476)
Workforce optimization charges - cost of goods sold 549  6,404 
EDC related liability valuation increase (decrease) - research and development 27,682  (11,656)
Workforce optimization charges - research and development 960  9,437 
Amortization related to intangible assets acquired through certain business combinations - selling, general and administrative 348  348 
EDC related liability valuation increase (decrease) - selling, general and administrative 18,454  (7,771)
Workforce optimization charges - selling, general and administrative 1,388  6,987 
Amortization of note discounts - other income (expense), net 504  674 
(Gain) loss on EDC related asset - other income (expense), net (61,325) 27,265 
Net income tax benefit on non-GAAP items (3,921) (1,898)
Non-GAAP net income $ 2,279,968  $ 1,851,442 
Non-GAAP net income per diluted share $ 1.82  $ 1.47 
U.S. GAAP net income per diluted share $ 1.81  $ 1.45 
U.S. GAAP and non-GAAP number of shares used for per diluted share calculation 1,256,032  1,257,325 



 
Reconciliation of U.S. GAAP Gross Margin, Operating Expenses, Operating Income and Operating Margin to Non-GAAP Gross Margin, Operating Expenses, Operating Income and Operating Margin
(in thousands, except percentages)
(unaudited) 
Three Months Ended
June 28,
2026		 March 29,
2026
U.S. GAAP gross margin $ 3,478,740  $ 2,910,527 
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations 2,668  2,668 
EDC related liability valuation increase (decrease) 15,379  (6,476)
Workforce optimization charges 549  6,404 
Non-GAAP gross margin $ 3,497,336  $ 2,913,123 
U.S. GAAP gross margin as a percent of revenue 51.7  % 49.8  %
Non-GAAP gross margin as a percent of revenue 52.0  % 49.9  %
U.S. GAAP operating expenses $ 965,252  $ 863,511 
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations (348) (348)
EDC related liability valuation (increase) decrease (46,136) 19,427 
Workforce optimization charges (2,348) (16,424)
Non-GAAP operating expenses $ 916,420  $ 866,166 
U.S. GAAP operating income $ 2,513,488  $ 2,047,016 
Non-GAAP operating income $ 2,580,916  $ 2,046,957 
U.S. GAAP operating margin 37.4  % 35.0  %
Non-GAAP operating margin 38.4  % 35.0  %
 
Lam Research Corporation Contact:
Ram Ganesh, Investor Relations, phone: 510-572-1615, e-mail: investor.relations@lamresearch.com